Evidence map›Paper›PMID 38784964›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease.

Inga Margret Antonsdottir, Byron Creese, Lambertus Klei, Mary Ann A DeMichele-Sweet, Elise A Weamer, Pablo Garcia-Gonzalez, Marta Marquie, Mercè Boada, Emilio Alarcón-Martín, Sergi Valero and 23 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Inga Margret AntonsdottirJohns Hopkins School of Nursing Baltimore Maryland USA.
Byron CreeseDepartment of Clinical and Biomedical Sciences Faculty of Health and Life Sciences University of Exeter Exeter UK.
Lambertus KleiDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.
Mary Ann A DeMichele-SweetDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.
Elise A WeamerDepartment of Neurology University of Pittsburgh Pittsburgh Pennsylvania USA.
Pablo Garcia-GonzalezResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
Marta MarquieResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
Mercè BoadaResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
Emilio Alarcón-MartínResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
Sergi ValeroResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
NIA‐LOAD Family Based Study Consortium, Alzheimer's Disease Genetics Consortium (ADGC), AddNeuroMed Consortium
Yushi LiuGlobal Statistical Science Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana USA.
Basavaraj HooliNeurodegeneration Research Lilly Research Laboratories Eli Lilly and Company Indianapolis Indiana USA.
Dag AarslandDepartment of Old Age Psychiatry Institute of Psychiatry Psychology and Neuroscience King's College London England.
Geir SelbaekNorwegian National Centre for Aging and Health Vestfold Hospital Trust Tønsberg Norway.
Sverre BerghResearch Centre of Age-related Functional Decline and Disease Innlandet Hospital Trust Ottestad Norway.
Arvid RongveDepartment of Research and Innovation Helse Fonna Haugesund Norway.
Ingvild SaltvedtGeriatric Department St. Olav Hospital University Hospital of Trondheim Trondheim Norway.
Håvard K SkjellegrindNord-Trøndelag Hospital Trust Levanger Norway.
Bo EngdahlNorwegian Institute of Public Health Oslo Norway.
Ole A AndreassenNORMENT, Institute of Clinical Medicine University of Oslo Oslo Norway.
Barbara BorroniCentre for Neurodegenerative Disorders University of Brescia Brescia Italy.
Patrizia MecocciInstitute of Gerontology and Geriatrics University of Perugia Perugia Italy.
Yehani WedatilakeResearch Centre of Age-related Functional Decline and Disease Innlandet Hospital Trust Ottestad Norway.
Richard MayeuxDepartments of Neurology Psychiatry and Epidemiology Columbia University New York New York USA.
Tatiana ForoudMedical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA.
Agustín RuizResearch Center and Memory Clinic ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain.
Oscar L LopezDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.
M Ilyas KambohDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.
Clive BallardDepartment of Clinical and Biomedical Sciences Faculty of Health and Life Sciences University of Exeter Exeter UK.
Bernie DevlinDepartment of Human Genetics University of Pittsburgh Pittsburgh Pennsylvania USA.
Constantine LyketsosRichman Family Precision Medicine Center of Excellence in Alzheimer's Disease Department of Psychiatry and Behavioral Sciences Johns Hopkins Bayview Johns Hopkins Medicine Baltimore Maryland USA.
Robert A SweetDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)U24AG056270 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gary Wayne Beecham, TATIANA M. FOROUD · 2017 to 2026
$31.4M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Christiane Reitz · 2020 to 2026
$30.1M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious OrderR01AG067501 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAYEUX, RICHARD P, MILLER, GARY W · 2020 to 2024
$11.7M
Prediction of Psychosis in Alzheimer DiseaseR01AG027224 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEET, ROBERT A · 2007 to 2021
$10.8M
Synaptic Resilience to Psychosis in Alzheimer DiseaseR01MH116046 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Julia K Kofler, ROBERT A SWEET · 2018 to 2026
$6.6M
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimer’s diseaseR01AG067015 · NIA · UNIVERSITY OF EXETER · PI KOFLER, JULIA K, LUNNON, KATIE · 2019 to 2023
$1.6M
Actigraphic Assessment of Sleep and Circadian Rest/Activity Rhythms in Persons with Alzheimer's Disease and their CaregiversF30AG071169 · NIA · JOHNS HOPKINS UNIVERSITY · PI ANTONSDOTTIR, INGA MARGRET · 2021 to 2023
$115k
NIA NIH HHS F30 AG071169NIA NIH HHS P30 AG066462NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG027224NIA NIH HHS R01 AG067015NIA NIH HHS R01 AG067501NIA NIH HHS U24 AG021886NIA NIH HHS U24 AG056270NIMH NIH HHS R01 MH116046
6 · The paper itself

Abstract

introductionIndividuals with Alzheimer's disease (AD) commonly experience neuropsychiatric symptoms of psychosis (AD+P) and/or affective disturbance (depression, anxiety, and/or irritability, AD+A). This study's goal was to identify the genetic architecture of AD+P and AD+A, as well as their genetically correlated phenotypes.

methodsGenome-wide association meta-analysis of 9988 AD participants from six source studies with participants characterized for AD+P AD+A, and a joint phenotype (AD+A+P).

resultsAD+P and AD+A were genetically correlated. However, AD+P and AD+A diverged in their genetic correlations with psychiatric phenotypes in individuals without AD. AD+P was negatively genetically correlated with bipolar disorder and positively with depressive symptoms. AD+A was positively correlated with anxiety disorder and more strongly correlated than AD+P with depressive symptoms. AD+P and AD+A+P had significant estimated heritability, whereas AD+A did not. Examination of the loci most strongly associated with the three phenotypes revealed overlapping and unique associations. DISCUSSION: AD+P, AD+A, and AD+A+P have both shared and divergent genetic associations pointing to the importance of incorporating genetic insights into future treatment development. Highlights: It has long been known that psychotic and affective symptoms are often comorbid in individuals diagnosed with Alzheimer's disease. Here we examined for the first time the genetic architecture underlying this clinical observation, determining that psychotic and affective phenotypes in Alzheimer's disease are genetically correlated.Nevertheless, psychotic and affective phenotypes in Alzheimer's disease diverged in their genetic correlations with psychiatric phenotypes assessed in individuals without Alzheimer's disease. Psychosis in Alzheimer's disease was negatively genetically correlated with bipolar disorder and positively with depressive symptoms, whereas the affective phenotypes in Alzheimer's disease were positively correlated with anxiety disorder and more strongly correlated than psychosis with depressive symptoms.Psychosis in Alzheimer's disease, and the joint psychotic and affective phenotype, had significant estimated heritability, whereas the affective in AD did not.Examination of the loci most strongly associated with the psychotic, affective, or joint phenotypes revealed overlapping and unique associations.

Indexed as

affective disturbanceAlzheimer's diseasegenome‐wide associationheritabilitypsychosis

Identifiers

PMID38784964
PMCPMC11114588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.